Jaw avascular bone necrosis associated with long-term use of biphosphonates [1]

Annals of Oncology

Volumn 16, Issue 7, 2005, Pages 1207-1208

  Sanna, Giuseppina ^a   Zampino, M G ^a   Pelosi, G ^a   Nole F ^a   Goldhirsch, A ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; OXYGEN; PAMIDRONIC ACID; ZOLEDRONIC ACID;

AVASCULAR NECROSIS; BONE BIOPSY; BONE DISEASE; BONE METASTASIS; BONE NECROSIS; BONE PAIN; BREAST CANCER; CURETTAGE; DRUG INDUCED DISEASE; DRUG MECHANISM; FISTULA; HUMAN; HYPERBARIC OXYGEN; JAW DISEASE; LETTER; LONG TERM CARE; MANDIBLE RESECTION; MASTICATION; OSTEOMYELITIS; PRIORITY JOURNAL; TOOTH BRUSHING; TOOTH EXTRACTION; CHEMICALLY INDUCED DISORDER; JAW; PATHOLOGY;

DIPHOSPHONATES; HUMANS; JAW; OSTEONECROSIS;

EID: 25444476035     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdi206     Document Type: Letter

References (5)

1. Lipton A, Coleman RE, Diel IJ, Mundy G. Update on the role of bisphosphonates in metastatic breast cancer. Semin Oncol 2001; 28 (Suppl 11): 2-91.
2. Marx RE. Pamidronate (Aredia) and Zolendronate (Zometa) induced avascular bone necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg 2003; 61: 1115-1118.
3. Migliorati CA. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 2003; 21: 4253-4254.
4. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: Review of 63 cases. J Oral Maxillofac Surg 2004; 62, 527-534.
5. Green JR, Bisphosphonates: Preclinical review. The Oncologist 2004; 204, 9 (Suppl 4): 3-13. d